Gossamer Bio, Inc. (GOSS)
2.52
0.00 (0.00%)
USD |
NASDAQ |
Jan 13, 11:44
Gossamer Bio Research and Development Expense (Quarterly): 45.54M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 173.65M |
| XOMA Royalty Corp. | 0.069M |
| Rezolute, Inc. | 13.15M |
| Axsome Therapeutics, Inc. | 40.04M |
| Crinetics Pharmaceuticals, Inc. | 89.45M |